What Semaglutide Actually Is (and Why Med Spas Got Into It)
Semaglutide is a GLP-1 receptor agonist — a class of drugs that mimics a gut hormone released after eating. It slows gastric emptying, reduces appetite, and signals satiety to the brain. Originally developed for type 2 diabetes (Ozempic), it was later FDA-approved for chronic weight management at higher doses under the brand name Wegovy.
Clinical trials showed Wegovy users losing an average of 15% of body weight over 68 weeks. That efficacy number, combined with a steep brand-name price tag and insurance coverage gaps, created demand that traditional healthcare channels couldn't satisfy — and med spas stepped into the gap.
Med spas were already attracting the demographic most interested in GLP-1 medications: patients with disposable income who prioritize appearance and wellness, with an existing relationship with an aesthetics provider. Adding a medically supervised weight loss program was a logical expansion, especially once compounding pharmacies made the economics work.
Who Is a Candidate
Good candidates for semaglutide at a med spa are adults with a BMI of 27 or higher with at least one weight-related condition (hypertension, type 2 diabetes, high cholesterol), or a BMI of 30 or higher without additional conditions. Anyone with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome should not use semaglutide. A qualified prescriber will review contraindications at intake.
Semaglutide is not a body contouring substitute. It addresses overall body weight through appetite suppression and metabolic changes. Patients looking to target specific areas of fat without significant weight loss are better served by treatments like CoolSculpting or Emsculpt NEO.
Cost Breakdown: Brand, Compounded, and Telehealth
| Source | Monthly Cost | Notes |
|---|---|---|
| Brand-name Wegovy (retail) | $1,300–$1,400 | With insurance, often $0–$25; without insurance, this is the real number |
| Brand-name Ozempic (off-label) | $900–$1,100 | Lower dose than Wegovy; prescribed off-label for weight loss |
| Med spa compounded semaglutide | $200–$500 | 503A pharmacy; in-person program with provider oversight |
| Telehealth compounded semaglutide | $179–$299 | Remote prescribing; less oversight but lower cost |
| Compounded tirzepatide (med spa) | $250–$600 | Newer molecule; slightly higher cost, potentially stronger results |
What Drives the Price at Med Spas
Med spa pricing varies by dose (which rises over the titration schedule), whether the program includes monthly check-ins and lab monitoring, and what compounding pharmacy the practice uses. A starter dose at 0.25mg/week costs less than a maintenance dose at 1mg or 2mg/week — so monthly costs typically increase over the first 3–4 months as doses step up.
Programs that include metabolic labs, body composition analysis, and dietary coaching are priced higher than inject-and-go models. The added cost is worth it for most patients — the clinical support is what differentiates a medical program from a poorly supervised one.
What's Not Included
Most med spa program prices don't include:
- Initial consultation fee ($75–$150 at many practices)
- Lab work (metabolic panel, thyroid, A1C) — typically $100–$250 if not covered by insurance
- Injection supplies (usually bundled, but ask)
- Anti-nausea medication for patients who experience GI side effects in early weeks
Budget approximately $300–$400 more than the quoted monthly dose cost for your first month when accounting for intake, labs, and supplies.
The Regulatory Situation in 2026
The FDA declared the semaglutide shortage over in February 2025. That ruling changed the legal landscape for compounding pharmacies — but it didn't ban compounded semaglutide outright. What it did was split the picture between two types of compounding pharmacies.
503A vs. 503B: The Distinction That Matters
503A pharmacies compound medications for specific patients based on a valid individual prescription. These pharmacies can still legally compound semaglutide in 2026 — the shortage ruling doesn't touch patient-specific compounding. Most legitimate med spa programs source from 503A pharmacies.
503B outsourcing facilities are bulk manufacturers that produce compounded drugs without patient-specific prescriptions for distribution to healthcare facilities. In April 2026, the FDA proposed removing semaglutide and tirzepatide from the 503B bulk compounding list and issued warning letters to facilities operating outside these rules. The proposal opened a public comment period through late June 2026 and has not been finalized.
The short version: med spa programs sourcing from 503A pharmacies with valid individual prescriptions are operating legally today. Programs sourcing from unregistered bulk compounders or offering medication without a prescribing provider are not.
What Changed for Patients
The practical impact for patients is that price-floor offers — spas charging $99 to $150/month that appeared during the shortage — are increasingly hard to find from legitimate sources. Prices have normalized upward as the easy-to-access bulk supply dried up. If a spa is still quoting $99/month for semaglutide without a physician or NP prescriber involved, that's a compliance red flag.
What a Legitimate Med Spa Program Looks Like
A compliant med spa GLP-1 program has a few non-negotiable elements:
Prescriber involvement
A licensed prescriber — MD, DO, NP, or PA — must evaluate the patient and write the prescription. This can be a physician on staff, a collaborating physician, or a telehealth prescriber integrated into the program. The prescription cannot be issued by an aesthetician, medical assistant, or by the patient completing a form with no clinical review.
Pharmacy transparency
A legitimate program will tell you exactly which compounding pharmacy fills their prescriptions. Ask for the pharmacy name and verify it's registered with the state board of pharmacy as a 503A facility. Refusal to disclose the pharmacy source is a hard stop.
Intake screening
Before your first injection, you should complete a health history review covering contraindications, medication interactions, thyroid history, and personal or family cancer history. A blood pressure check at minimum — ideally a metabolic panel — should precede the prescription.
Dose titration protocol
GLP-1 programs should start at low doses (0.25mg semaglutide weekly for the first four weeks) and step up on a schedule tied to patient tolerance, not administrative convenience. A spa that starts everyone at a high dose to show faster results without monitoring side effects is cutting a corner that matters.
What a Red-Flag Program Looks Like
Walk away if the program offers no prescriber consultation, won't name their pharmacy, guarantees results without a screening, charges dramatically below market without explanation, or suggests adding semaglutide to an IV drip or topical product. None of those delivery methods work for semaglutide — it's a subcutaneous injection or oral tablet and cannot be effectively delivered any other way.
Semaglutide vs. Tirzepatide: Which One Are Spas Offering?
Many med spas that started with semaglutide now offer tirzepatide as an alternative. Tirzepatide (brand names Zepbound for weight loss, Mounjaro for diabetes) works on both GLP-1 and GIP receptors. Clinical data shows slightly better weight loss outcomes than semaglutide at equivalent doses — trial participants lost an average of 20–22% of body weight versus 15% for semaglutide.
| Factor | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | GLP-1 + GIP dual agonist |
| Average weight loss (clinical trial) | ~15% body weight | ~20–22% body weight |
| Brand names | Wegovy, Ozempic | Zepbound, Mounjaro |
| Compounded med spa cost | $200–$500/month | $250–$600/month |
| Side effect profile | Nausea, constipation common early | Similar; some report better GI tolerance |
| Regulatory status (compounded) | 503A legal, 503B proposed restrictions | Same framework applies |
For patients who tried semaglutide and hit a plateau or had persistent GI issues, tirzepatide is worth discussing with a prescriber. The price premium is modest relative to the potential difference in outcomes. That said, the research base for semaglutide is more established and most prescribers are more comfortable adjusting protocols for it.
What to Ask Before You Commit to a Program
- Who writes my prescription? Get a name and credential. If the answer is vague, keep asking.
- Which pharmacy do you use? Get the pharmacy name. Verify it online as a licensed 503A compounding pharmacy in your state.
- What does the intake process include? A serious answer mentions health history, contraindication screening, and either a blood pressure check or lab review.
- What's the titration schedule? Should start at 0.25mg weekly for semaglutide and increase on a clinical protocol, not faster.
- What's included in the monthly price? Clarify what's bundled (supplies, check-ins, follow-up calls) and what's extra (labs, nausea meds, consultation fees).
- What's the cancellation policy? Reputable programs don't lock patients into multi-month prepayment plans with no exit.
FAQ
Q: How much does semaglutide cost at a med spa in 2026?
Compounded semaglutide at a med spa typically costs $200–$500 per month depending on dose, location, and what's included in the program. This is significantly less than brand-name Wegovy ($1,300–$1,400/month retail) but higher than some telehealth platforms that offer compounded versions at $179–$299/month with less in-person oversight.
Q: Is compounded semaglutide still legal in 2026?
Yes, with conditions. 503A compounding pharmacies can still legally compound semaglutide for patients with individual prescriptions. The FDA's April 2026 proposal targets 503B bulk facilities, not patient-specific 503A compounding. Med spas sourcing from licensed 503A pharmacies with a valid prescriber are operating legally under current rules.
Q: What's the difference between Ozempic, Wegovy, and compounded semaglutide?
All three contain the same active molecule — semaglutide. Ozempic is FDA-approved for type 2 diabetes at up to 2mg weekly. Wegovy is FDA-approved for weight management at up to 2.4mg weekly. Compounded semaglutide from a 503A pharmacy contains the same active ingredient formulated per the individual prescription, but is not an FDA-approved drug itself.
Q: Can a med spa prescribe semaglutide?
The prescription must come from a licensed prescriber — an MD, DO, NP, or PA. A med spa can employ or partner with a prescriber to offer GLP-1 programs, but the medication cannot be dispensed without a clinical evaluation and valid prescription. Spas that dispense without this step are operating outside the law.
Q: How much weight can I lose on semaglutide?
Clinical trials show average weight loss of approximately 15% of starting body weight over 68 weeks at the full Wegovy dose of 2.4mg weekly. Individual results vary significantly based on starting weight, dose achieved, dietary changes, and physical activity. Semaglutide is most effective when combined with lifestyle modification.
Q: How does semaglutide compare to CoolSculpting or body contouring treatments?
They address different problems. Semaglutide drives overall weight loss through appetite suppression and metabolic changes. Body contouring treatments like CoolSculpting reduce fat in specific areas without affecting overall body weight. For patients who have lost significant weight on semaglutide and want to address specific areas that didn't respond proportionally, combining both is common.
Q: Are there side effects?
The most common side effects are GI-related: nausea, constipation, and in some patients vomiting, particularly during dose increases. These typically improve after 4–8 weeks as the body adjusts. Starting at a low dose and titrating slowly is the primary way to minimize GI impact. More serious but rare risks include pancreatitis, gallbladder disease, and a theoretical thyroid risk that led to the contraindication in patients with thyroid cancer history.